Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GMP Warning To Sandoz Questions Continued Lot Release; Will FDA Block It?

Executive Summary

FDA's warning letter to Sandoz over violations of good manufacturing practices suggests the agency is taking a stronger, but still measured, tone in its GMP oversight

You may also be interested in...



Sandoz GMP Warning Letter: Is The Problem Documentation, Or Leadership?

Upper management at Novartis and Sandoz are responsible for repeated cGMP violations at three Sandoz plants, FDA suggests. The agency’s warning letter, aimed at three sites in North Amercia, includes what may become new biolerplate instructions on drug shortages.

Sandoz Gets New Global, U.S. CEOs: Will Flat Regional Structure Spark Growth?

Sandoz's new CEO Jeff George is flattening out the firm's global organization to position sales groups closer to customers, and he's hired former Barr CEO Christine Mundkur to shape up the U.S. operation in reforms aimed at returning the world's second largest generics business to strong growth

Sandoz Gets New Global, U.S. CEOs: Will Flat Regional Structure Spark Growth?

Sandoz's new CEO Jeff George is flattening out the firm's global organization to position sales groups closer to customers, and he's hired former Barr CEO Christine Mundkur to shape up the U.S. operation in reforms aimed at returning the world's second largest generics business to strong growth

Related Content

UsernamePublicRestriction

Register

PS050043

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel